Gamelin Erick 4
4 · Acrivon Therapeutics, Inc. · Filed Feb 16, 2024
Insider Transaction Report
Form 4
Gamelin Erick
Chief Development Officer
Transactions
- Tax Payment
Common Stock
2024-02-14$3.40/sh−468$1,591→ 18,167 total
Footnotes (1)
- [F1]Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.